pyrroles has been researched along with Osteonecrosis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (16.67) | 29.6817 |
| 2010's | 15 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Antonuzzo, L; Balestri, V; Brugia, M; Costanzo, FD; Giommoni, E; Laffi, A; Lunghi, A; Mazzoni, F; Mela, MM; Petreni, P | 1 |
| Estilo, CL; Huryn, JM; Liang, STY; Owosho, AA; Sax, AZ; Wu, K; Yom, SK | 1 |
| Boralevi, F; Fricain, JC; Sibaud, V; Vigarios, E | 1 |
| Bedogni, A; Bettini, G; Bonacina, R; Campisi, G; Di Fede, O; Fusco, V; Guglielmini, P; Lo Re, G; Merigo, E; Paglino, C; Porta, C; Saia, G; Scoletta, M; Vescovi, P | 1 |
| Arriba, Ld; Casañas, E; Hernández, G; López-Pintor, RM; Ramírez, L | 1 |
| Soós, B; Szalma, J; Vajta, L | 1 |
| Basso, U; Bedogni, A; Brunello, A; Saia, G; Scaglione, D | 1 |
| Ayllon, J; Cros, C; Launay-Vacher, V; Medioni, J; Oudard, S; Spano, JP | 1 |
| Hansen, T; Jäger, E; Koch, FP; Wagner, W; Walter, C | 1 |
| Bozas, G; Maraveyas, A; Ramasamy, V; Roy, A | 1 |
| Eufinger, H; Hoefert, S | 1 |
| Pazianas, M | 1 |
| Bamias, A; Dimitriadis, G; Dimopoulos, MA; Economopoulos, T; Migkou, M; Nicolatou-Galitis, O; Pectasides, D; Psyrri, A; Raber-Durlacher, JE | 1 |
| Fleissig, Y; Lehman, H; Regev, E | 1 |
| Kriegelstein, S; Messlinger, K; Steiner, T; Troeltzsch, M; Woodlock, T | 1 |
| Berkers, J; Beuselinck, B; Body, JJ; Debruyne, P; Dumez, H; Elaidi, R; Karadimou, A; Lerut, E; Paridaens, R; Rogiers, A; Schöffski, P; Van Cann, T; Van Poppel, H; Willems, L; Wolter, P | 1 |
| Belmont, HM; Lydon, E | 1 |
6 review(s) available for pyrroles and Osteonecrosis
| Article | Year |
|---|---|
Osteonecrosis of the Jaw and Angiogenesis inhibitors: A Revival of a Rare but Serous Side Effect.
Topics: Angiogenesis Inhibitors; Bevacizumab; Humans; Indoles; Jaw Diseases; Niacinamide; Osteonecrosis; Phenylurea Compounds; Pyridines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Sorafenib; Sunitinib | 2017 |
[Oral toxicity of targeted anticancer therapies].
Topics: Angiogenesis Inhibitors; Benzamides; ErbB Receptors; Glossitis, Benign Migratory; Humans; Hyperpigmentation; Imatinib Mesylate; Indoles; Maxillary Diseases; Molecular Targeted Therapy; Mouth Mucosa; Osteonecrosis; Piperazines; Protein Kinase Inhibitors; Proto-Oncogene Proteins B-raf; Pyrimidines; Pyrroles; Radiation Injuries; Radiotherapy; Stomatitis; Stomatitis, Aphthous; Sunitinib; TOR Serine-Threonine Kinases | 2014 |
Osteonecrosis of the Jaw in Patients With Metastatic Renal Cell Cancer Treated With Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Diphosphonates; Female; Humans; Imidazoles; Indoles; Italy; Jaw; Kidney Neoplasms; Male; Middle Aged; Osteonecrosis; Pyrroles; Retrospective Studies; Sunitinib; Zoledronic Acid | 2015 |
New Non-Bisphosphonate Drugs that Produce Osteonecrosis of the Jaws.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Bone Density Conservation Agents; Denosumab; Humans; Indoles; Jaw Diseases; Osteonecrosis; Pyrroles; Sunitinib | 2015 |
Osteonecrosis of the jaw and the role of macrophages.
Topics: Alendronate; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bone Density Conservation Agents; Denosumab; Diphosphonates; Etidronic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Imidazoles; Indoles; Jaw Diseases; Macrophages; Magnetic Resonance Imaging; Mevalonic Acid; Monocytes; Mouth Mucosa; Osteoclasts; Osteomyelitis; Osteonecrosis; Positron-Emission Tomography; Pyrroles; Radiography, Panoramic; RANK Ligand; Risedronic Acid; Risk Factors; Signal Transduction; Sunitinib; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid | 2011 |
Physiology and pharmacology of nonbisphosphonate drugs implicated in osteonecrosis of the jaw.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Bone Density Conservation Agents; Denosumab; Humans; Indoles; Jaw Diseases; Osteonecrosis; Pyrroles; RANK Ligand; Sunitinib | 2012 |
1 trial(s) available for pyrroles and Osteonecrosis
| Article | Year |
|---|---|
Avascular necrosis prevention with lipitor in lupus erythematosus.
Topics: Anticholesteremic Agents; Atorvastatin; Double-Blind Method; Heptanoic Acids; Humans; Lupus Erythematosus, Systemic; Osteonecrosis; Pyrroles | 2005 |
11 other study(ies) available for pyrroles and Osteonecrosis
| Article | Year |
|---|---|
Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bevacizumab; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Denosumab; Diphosphonates; Female; Humans; Imidazoles; Incidence; Indoles; Ipilimumab; Jaw Diseases; Male; Middle Aged; Neoplasms; Osteonecrosis; Pamidronate; Pyrroles; Retrospective Studies; Sunitinib; Zoledronic Acid | 2018 |
[Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
Topics: Adult; Antineoplastic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Indoles; Mandible; Oral Surgical Procedures; Osteonecrosis; Pyrroles; Sunitinib; Treatment Outcome; Zoledronic Acid | 2015 |
Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Dental Fistula; Humans; Indoles; Jaw Diseases; Kidney Neoplasms; Lung Neoplasms; Male; Middle Aged; Osteonecrosis; Pyrroles; Sunitinib | 2009 |
Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
Topics: Angiogenesis Inhibitors; Diphosphonates; Humans; Imidazoles; Indoles; Jaw Diseases; Osteonecrosis; Pyrroles; Sunitinib; Zoledronic Acid | 2009 |
Osteonecrosis of the jaw related to sunitinib.
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Humans; Indoles; Kidney Neoplasms; Male; Mandibular Diseases; Middle Aged; Molar; Neoplasm Recurrence, Local; Nephrectomy; Osteonecrosis; Postoperative Complications; Pyrroles; Sunitinib; Tooth Extraction | 2011 |
Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Diphosphonates; Drug Synergism; Humans; Imidazoles; Indoles; Infusions, Intravenous; Kidney Neoplasms; Male; Mandibular Diseases; Middle Aged; Neoplasm Staging; Osteonecrosis; Pyrroles; Sacrum; Spinal Neoplasms; Sunitinib; Zoledronic Acid | 2010 |
Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Carcinoma, Renal Cell; Diphosphonates; Humans; Indoles; Injections, Intravenous; Kidney Neoplasms; Mandibular Diseases; Middle Aged; Mucositis; Osteonecrosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Risk Factors; Stomatitis; Sunitinib; Tooth Extraction | 2010 |
Bevacizumab, sunitinib: osteonecrosis of the jaw.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bevacizumab; Humans; Indoles; Jaw Diseases; Osteonecrosis; Pyrroles; Sunitinib; Vascular Endothelial Growth Factor A | 2011 |
Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carcinoma, Renal Cell; Female; Gingival Hemorrhage; Humans; Indoles; Kidney Neoplasms; Mandibular Diseases; Middle Aged; Neoplasm Metastasis; Osteonecrosis; Pyrroles; Sunitinib; Treatment Outcome; Young Adult | 2012 |
Sunitinib related osteonecrosis of jaw: a case report.
Topics: Actinomyces; Actinomycosis; Amoxicillin; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma, Renal Cell; Clavulanic Acid; Female; Humans; Indoles; Kidney Neoplasms; Mandible; Mandibular Diseases; Middle Aged; Molar, Third; Osteonecrosis; Pyrroles; Sunitinib; Tooth Extraction; Tooth Socket | 2012 |
Concomitant oral tyrosine kinase inhibitors and bisphosphonates in advanced renal cell carcinoma with bone metastases.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Disease-Free Survival; Female; Humans; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Niacinamide; Osteonecrosis; Phenylurea Compounds; Prognosis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrroles; Retrospective Studies; Sorafenib; Sunitinib; Treatment Outcome | 2012 |